Understand the reproductive hospital’s published team and service catalogue, with separate explanations of clinic references and Jihaoyun-linked package documents.
Independent provider profile · Sources reviewed 28 October 2026
Tang’s introduction places the reproductive hospital at Gorky Street 129 and dates opening to July 2025. The service catalogue combines medical procedures, donor-material services, preservation, travel coordination and named packages.
The source describes thirteen service/package entries. An individual procedure, donor-bank reference and multi-cycle programme are different offers. This profile separates them and preserves the published starting references without treating them as comparable total-treatment prices.
The hospital introduction reports opening in Bishkek.
The provider describes a division of responsibility: Yang Zhihong oversees laboratory/genetic-testing direction, Li Bo handles reproductive clinical stages, and Marc covers obstetric care. Those published roles are distinct from a confirmed appointment schedule or independently verified overseas credential.
Hospital director · Embryology & genetic diagnosis
Tang’s team page assigns him oversight of the embryology laboratory and genetic-testing approach. Its descriptions of overseas academic and laboratory appointments remain provider statements.
Read specialist profile →
Reproductive medicine · Endocrinology
The team page assigns him clinical responsibility for stimulation, retrieval and transfer, with monitoring and medication decisions followed by the clinical and nursing teams.
Read specialist profile →
Obstetrics & gynaecology
Tang assigns this team member obstetrics-gynaecology and pregnancy-management responsibilities. The source does not establish a complete Latin-script name.
Sources & identity details →Services described by the provider. Clinical suitability and the exact treatment plan require an individual assessment.
The source has separate ICSI and in-vitro-maturation entries. These are different clinical pathways; the listed rationale and price do not establish that either is appropriate for every patient.
Tang uses PGT-A/M/P terminology in its catalogue. Ask for the exact analysis, method, laboratory and evidence relevant to the proposed test. The source’s wording is not treated as a guarantee of embryo health or a standard indication for testing.
The catalogue separates donor-bank resources from a broader third-party ART entry. Material allocation, screening, legal eligibility and the rest of the medical pathway need their own written scope.
Conventional egg-freezing and a separately named DLI item appear at different starting references. The page does not give enough technical detail to establish what distinguishes the DLI label; do not assume it is an equivalent package.
The information below shows which related services appear in provider publications or supplied quotations. “Not established” means the reviewed sources do not answer the question. Confirm availability with the medical provider and obtain separate advice on legal eligibility.
The public catalogue describes donor resources; supplied documents contain additional donor charges and donor-related conditions.
Read the source record →The catalogue and supplied terms describe sperm resources and separate material/information charges. Confirm the supplying entity and governing version.
Read the source record →The received-embryo carrier pathway appears in Jihaoyun documents; the March and July totals differ, and transport has its own scope.
Read the source record →The supplied material links Tang with Jihaoyun. Medical treatment, coordination, pregnancy management and legal services must be allocated to named parties.
Read the source record →A hospital, coordinator, donor-material supplier and pregnancy-management service may be different parties. Read the legal identity and agreement questions →
The team page assigns embryo culture and biopsy to the laboratory, with genetics-background expertise involved in interpretation. It names a director for the technical approach but does not independently identify every laboratory operator or external testing provider.
The website refers to PGT and time-lapse research in the director’s biography. Research history, local equipment, the test actually offered and evidence of benefit are separate issues. This listing does not reproduce success-rate promises as audited results.
An identifying logo is shown where suitable facility photographs have not been established.
Clinical and laboratory responsibilities →The public catalogue and supplied package documents differ in currency, scope and date. The fee page separates them and explains the March–July changes.
Explore Tang IVF fees & scope →Original references use ¥ on the Chinese-language page and are recorded here as CNY, subject to written confirmation. They are starting points, not a full travel budget. “Multiple” or “unlimited” wording is a contract description to clarify, not a medical guarantee or confirmation that every advertised selection purpose is permissible.
Confirm the seller, currency, validity, inclusions, exclusions and the cost of changes to the plan.
The source describes initial online/telephone contact, an expert appointment and assessment before the treatment proposal.
Its process describes agreeing treatment content, cycle scope and responsibilities before starting. Confirm the differences between a standalone service and a named package in the written agreement.
The team page describes the treating clinician and nursing team following monitoring and medication decisions, with embryology results communicated by laboratory staff. It reports Chinese, Russian and English services.
The provider reports Chinese, Russian and English services and describes translation, airport, accommodation and travel coordination. Ask which arrangements are included in the written agreement.
Prepare for your Tang IVF consultation: records, timing and follow-up →
129 Gorky Street
Bishkek, Kyrgyzstan
Mon–Sat 09:00–17:00, per provider website
The hospital’s public Chinese-language catalogue uses ¥ starting references, recorded here as CNY subject to confirmation. The supplied Jihaoyun documents quote USD packages. They have different scopes and are not presented as currency conversions.
The supplied July image lists each of the six carrier-programme totals USD 10,000 above the corresponding March figures. The documents do not establish why. Obtain one current version rather than choose the lower total or combine terms.
The supplied client brochure identifies Tang as its treatment hospital, but that does not independently establish common ownership or a single seller. Ask who supplies medical care, coordination and each invoice, and obtain the full legal names.
Provider information and editorial planning questions. The complete guide separates preparation, appointment arrangements and follow-up.
Tang publishes a statement identifying tangivf.net as its official domain. This is recorded as its declaration; similarly named sites are not merged into this profile.
Checked 28 October 2026. Public provider information and supplied quotations are different source categories. This research is not an independent inspection, credential check or clinical outcome audit.
Provider identity, licences and agreements →
Suggest a correction →Clinical and embryology roles, with individual biographies.
Fee sources, programme scope and questions before payment.
First contact, existing records, timing and follow-up.
This Tang IVF channel is independently researched and published by Kyrgyzstan IVF. It is not Tang IVF’s official website.
Return to all clinics →